Gsa Capital Partners LLP Bio Rad Laboratories, Inc. Transaction History

Gsa Capital Partners LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $213,721 - $291,768	518 New	518 $216,000
Q1 2022 May 11, 2022	SELL	$524.57 - $735.42 $261,235 - $366,239	-498 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $353,002 - $395,750	498 New	498 $376,000
Q3 2020 Nov 06, 2020	SELL	$454.43 - $535.6 $374,450 - $441,334	-824 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$334.87 - $493.06 $275,932 - $406,281	824 New	824 $372,000
Q4 2019 Feb 12, 2020	SELL	$319.73 - $374.2 $609,725 - $713,599	-1,907 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$304.55 - $345.24 $580,776 - $658,372	1,907 New	1,907 $635,000
Q4 2018 Feb 12, 2019	SELL	$220.1 - $309.0 $785,316 - $1.1 Million	-3,568 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$289.28 - $326.15 $65,087 - $73,383	-225 Reduced 5.93%	3,568 $1.12 Million
Q2 2018 Aug 09, 2018	BUY	$244.1 - $303.88 $426,442 - $530,878	1,747 Added 85.39%	3,793 $1.09 Million
Q1 2018 May 11, 2018	SELL	$233.97 - $274.11 $427,229 - $500,524	-1,826 Reduced 47.16%	2,046 $512,000
Q4 2017 Feb 14, 2018	BUY	$216.94 - $271.3 $839,991 - $1.05 Million	3,872	3,872 $924,000

455

17.7M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.89B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.